ADAPTIVE BIOTECHNOLOGIES for ADAPTIVE BIOTECHNOLOGIES
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to T cells, COVID testing, pandemic preparedness and immune medicine H.R. 6102 and S. 3404, The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2020, all provisions H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021 S. 3062 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, FY2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | covered legislative branch official |
Medicare/Medicaid MMM
H.R. 1946 and S. 1873- Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 H.R. 5745, COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA LYNN BRADLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.